Ignite Creation Date:
2024-05-05 @ 5:03 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00373217
Status:
TERMINATED
Last Update Posted:
2022-09-21
First Post:
2006-09-06
Brief Title:
Vaccine Therapy Paclitaxel and Carboplatin in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Ovarian Cancer Primary Peritoneal Cancer or Fallopian Tube Cancer
Sponsor:
Craig L Slingluff Jr
Organization:
University of Virginia
Organization Data
Organization:
University of Virginia
Class:
OTHER
Study ID:
10134
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Craig L Slingluff Jr
Lead Sponsor Class:
OTHER
Responsible Party:
Craig L Slingluff Jr
Responsible Party Title:
Professor of Surgery
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
University of Virginia
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |